TNF PRODUCTION AND HLA ANTIGENS IN PATIENTS WITH SILICOSIS.
Gerbase-DeLima M, Setta JH, Ribeiro O G, Bagatin E.
Department of Pediatrics, Escola Paulista de Medicina, UNIFESP, São
Paulo, SP, Brazil.
Silicosis is a chronic progressive granulomatous and fibrotic
lung disease caused by inhaled silica. Considering that a pivotal role
of TNF has been demonstrated in silica-induced pulmonary fibrosis in mice
and that the level of TNF secretion in humans has been correlated with
some HLA haplotypes, the aim of this study was: (1) to evaluate the production
of TNF by silicotic patients as compared to non-silicotic individuals who
had been occupationally exposed to silica (exposed controls) and to non-exposed
normal controls; (2) to search for an association between HLA antigens
and silicosis. The silicotics and the exposed controls did not differ in
terms of intensity or time of exposure to silica dust. The TNF production
was determined in heparinized whole blood (1 ml) stimulated with 10 mg
of lipopolysaccharide (LPS, Sigma), at 37oC, for 6 hours. The bioactive
TNF was measured in the plasma by the L929 bioassay. HLA-A, B, DR and DQ
antigens were determined in 50 silicotic patients and their frequencies
were compared (Fisher's exact test) to those of an ethnically matched control
population sample. The median TNF production by silicotic patients (n=38),
exposed controls (n=39) and non-exposed controls (n=15) was 9.7, 7.7, and
2.0 ng/ml, respectively (silicotic x exposed controls: P = 0.05; exposed
controls x non exposed controls: P < 0.0001). Comparison of HLA antigenic
frequencies between silicotic patients and controls did not disclose any
significant association. We concluded that: a) the in vivo exposure to
silica is clearly associated with an increased in vitro production of TNF;
b) the difference between the TNF production by the silicotic patients
and by the exposed controls, albeit statistically significant, is quite
small and thus of questionable biological significance; c) there is no
association between HLA- A, B, DR or DQ antigens and silicosis.